1. Home
  2. VRAX vs LGHL Comparison

VRAX vs LGHL Comparison

Compare VRAX & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.66

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

LGHL

Lion Group Holding Ltd.

HOLD

Current Price

$5.20

Market Cap

3.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
LGHL
Founded
2013
2015
Country
United Kingdom
Singapore
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.3M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
VRAX
LGHL
Price
$0.66
$5.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
14.7M
16.8K
Earning Date
01-01-0001
04-30-2024
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,986.00
N/A
Revenue This Year
$217,274.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$3.93
52 Week High
$3.20
$213.20

Technical Indicators

Market Signals
Indicator
VRAX
LGHL
Relative Strength Index (RSI) 69.02 65.85
Support Level $0.39 $0.30
Resistance Level $0.43 $8.65
Average True Range (ATR) 0.06 0.59
MACD 0.02 0.64
Stochastic Oscillator 55.35 58.70

Price Performance

Historical Comparison
VRAX
LGHL

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

Share on Social Networks: